-transparent.png){kind=logo}
N-substituted cyclic imides of phthalimide, 2,3-dihydrohalazine-1,4-dione, and diphenimide were shown to reduce the serum uric acid levels in normal and hyperuric mice at 20 mg/kg/day I.P. for 14 days. The agents were potent inhibitors of commercial xanthine dehydrogenase and xanthine oxidase enzyme activities with IC50 values from 10(-7) to 10(-8) M concentrations of drug.
Related Publications
I H Hall, and
J P Scoville, and
D J Reynolds, and
R Simlot, and
P Duncan
September 1969,
Journal of medicinal chemistry,
I H Hall, and
J P Scoville, and
D J Reynolds, and
R Simlot, and
P Duncan
September 2011,
European journal of medicinal chemistry,
I H Hall, and
J P Scoville, and
D J Reynolds, and
R Simlot, and
P Duncan
May 2004,
Bioorganic & medicinal chemistry,
I H Hall, and
J P Scoville, and
D J Reynolds, and
R Simlot, and
P Duncan
February 2017,
Bioorganic & medicinal chemistry letters,
I H Hall, and
J P Scoville, and
D J Reynolds, and
R Simlot, and
P Duncan
December 2015,
Oncotarget,
I H Hall, and
J P Scoville, and
D J Reynolds, and
R Simlot, and
P Duncan
November 1966,
Journal of medicinal chemistry,
I H Hall, and
J P Scoville, and
D J Reynolds, and
R Simlot, and
P Duncan
April 2010,
Bioorganic & medicinal chemistry letters,
I H Hall, and
J P Scoville, and
D J Reynolds, and
R Simlot, and
P Duncan
September 1984,
Research communications in chemical pathology and pharmacology,
I H Hall, and
J P Scoville, and
D J Reynolds, and
R Simlot, and
P Duncan
May 1996,
Farmaco (Societa chimica italiana : 1989),
I H Hall, and
J P Scoville, and
D J Reynolds, and
R Simlot, and
P Duncan
August 2019,
Future medicinal chemistry,
